Literature DB >> 15173122

CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation.

Keisuke Takeshita1, Tsugiko Yamasaki, Koichi Nagao, Hiromi Sugimoto, Michitaka Shichijo, Florian Gantner, Kevin B Bacon.   

Abstract

Chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes, CRTH2, is a cognate receptor for prostaglandin (PG) D(2) and, in humans, is suggested to play a functional role in Th2-dependent allergic inflammation. While peripheral blood leukocytes expressing high levels of surface CRTH2 have been detected in disease, little is known of the functional significance of CRTH2 in disease etiology. We have utilized a Th2-dependent murine model of FITC-induced contact hypersensitivity to assess the role, if any, CRTH2-PGD(2) may play in the elicitation or maintenance of such pathobiology. Expression of both PGD(2) and CRTH2 in lesional skin was paralleled by the release of the chemoattractants LTB(4) and the chemokine KC, as well as a profuse dermal neutrophilic and eosinophilic infiltrate, closely paralleling the acute inflammatory pathology observed in human atopic dermatitis. A small molecule CRTH2 antagonist, but not a selective PGD(2)R (DP) receptor antagonist, was able to completely abrogate these responses. Inflammatory cascades mediated by CRTH2 ligation may therefore represent an important early step in the elicitation and maintenance of Th2-dependent skin inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173122     DOI: 10.1093/intimm/dxh096

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  20 in total

1.  Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses.

Authors:  Ryan P Larson; Simone C Zimmerli; Michael R Comeau; Andrea Itano; Miyuki Omori; Masanori Iseki; Conrad Hauser; Steven F Ziegler
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

2.  A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.

Authors:  Shân L Gyles; Luzheng Xue; Elizabeth R Townsend; Frank Wettey; Roy Pettipher
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

3.  Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2.

Authors:  Yoshihiro Yamamoto; Shinobu Otani; Hiroyuki Hirai; Kinya Nagata; Kosuke Aritake; Yoshihiro Urade; Shuh Narumiya; Hiroo Yokozeki; Masataka Nakamura; Takahiro Satoh
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

4.  Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.

Authors:  Stefano Crosignani; Catherine Jorand-Lebrun; Patrick Page; Gordon Campbell; Véronique Colovray; Marc Missotten; Yves Humbert; Christophe Cleva; Jean-François Arrighi; Marilène Gaudet; Zoe Johnson; Pamela Ferro; André Chollet
Journal:  ACS Med Chem Lett       Date:  2011-06-09       Impact factor: 4.345

5.  The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity.

Authors:  Asako Ogawa; Ayumi Yoshizaki; Koichi Yanaba; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2010-02-25       Impact factor: 8.551

6.  A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes.

Authors:  Shân L Vinall; Elizabeth R Townsend; Roy Pettipher
Journal:  Immunology       Date:  2007-04-16       Impact factor: 7.397

7.  CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis.

Authors:  Makoto Ishii; Koichiro Asano; Ho Namkoong; Sadatomo Tasaka; Kosuke Mizoguchi; Takahiro Asami; Hirofumi Kamata; Yoshifumi Kimizuka; Hiroshi Fujiwara; Yohei Funatsu; Shizuko Kagawa; Jun Miyata; Ken Ishii; Masataka Nakamura; Hiroyuki Hirai; Kinya Nagata; Steven L Kunkel; Naoki Hasegawa; Tomoko Betsuyaku
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

8.  Depletion of major pathogenic cells in asthma by targeting CRTh2.

Authors:  Tao Huang; Meredith Hazen; Yonglei Shang; Meijuan Zhou; Xiumin Wu; Donghong Yan; Zhonghua Lin; Margaret Solon; Elizabeth Luis; Hai Ngu; Yongchang Shi; Arna Katewa; David F Choy; Nandhini Ramamoorthi; Erick R Castellanos; Mercedesz Balazs; Min Xu; Wyne P Lee; Marissa L Matsumoto; Jian Payandeh; Joseph R Arron; Jo-Anne Hongo; Jianyong Wang; Isidro Hötzel; Cary D Austin; Karin Reif
Journal:  JCI Insight       Date:  2016-05-19

9.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.

Authors:  Rabindra Tirouvanziam; Yael Gernez; Carol K Conrad; Richard B Moss; Iris Schrijver; Colleen E Dunn; Zoe A Davies; Leonore A Herzenberg; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

Review 10.  The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

Authors:  R Pettipher
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.